MRTX

Mirati Therapeutics (MRTX)

Mirati Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MRTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/02/15	04:51	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/02/14	23:13	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/02/03	06:05	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/25	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/25	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/25	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/24	10:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/24	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/24	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/24	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/24	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/24	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/24	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:31	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:31	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:31	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:31	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:31	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:31	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:30	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:30	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:30	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:30	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:30	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:30	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:28	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:27	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	23:17	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/23	22:48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRTX	Mirati Therapeutics Inc
2024/01/19	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRTX	Mirati Therapeutics Inc